Gelonghui, May 9, Fuxiang Pharmaceutical (300497)Royalacescasino.SZ) expressed on the investor interactive platformRoyalacescasinoSynthetic biology is a new discipline which uses renewable biomass as raw material and organism as production medium to transform or create artificial life system. Synthetic biology has the characteristics of clean, efficient and renewable, and has the potential to completely subvert the existing pattern in both science and technology and industrial innovation, which is an important development direction of the company. At present, the company has established a multi-functional synthetic biological-biological fermentation production line, and has accumulated profound experience in biological fermentation technology, mainly used in the fields of medicine and food. A variety of enzyme preparations, hydroxyproline, microbial protein and other products of the company have applied synthetic biology technology. Among them, the company's microbial fermentation protein has achieved a pilot production scale of 1000 tons. In order to meet the market demand, the company plans to invest in the construction of a comprehensive utilization project of 200000 tons of microbial protein and its resources (the first phase). After the project is completed and put into production, the project can produce 20, 000 tons of microbial protein and 50, 000 tons of amino acid water-soluble fertilizer, and the project is being carried out in an orderly manner. At present, the business has not had a significant impact on the company's performance.
